Do you want to be a part of a growth journey where your contributions can make a real difference? A journey where the commitment is to improve the life of patients with severe and chronic diseases.
We are now looking for a new CFO for Camurus next phase of growth - building on a very positive financial development, international expansion, a strong product portfolio and R&D pipeline.
For further information, please contact Christian Nyhlén, Mercuri Urval, phone +46 733 66 75 76 or christian.nyhlen@mercuriurval.com
About the company
Camurus is a Swedish science-led pharmaceutical company committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic diseases.
Read more about Camurus here